Thomas S Reger

This inventor holds 23 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 12 EPO patents, primarily in Orexin Receptor Antagonists. Top assignees: Merck Sharp + Dohme Corp., Merck + Co., Inc.. Active years: 2007-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas S Reger. Retrieved from https://idiyas.com/inventor/thomas-s-reger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 (Patent Applications = 4)

% Patents Active = 91.3

CIPO Patents = 2

EPO Patents = 12 (Patent Applications = 10)

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 89(Granted Patents)

Location History:

San Diego, CA (US) (2007 - 2009)
Lansdale, NJ (US) (2016)
Lansdale, PA (US) (2009 - 2018)

Company Filing History:

19 out of 2,405

Merck Sharp + Dohme Corp.

Years Active: 2007-2018

Loading Chart...

Areas of Expertise:

Orexin Receptor Antagonists

PDE10 Inhibitors

Diazepane

Triazoles

Azetidine

Calcium Channel Antagonists

Tetrazole Modulators

Heterocycle

Prodrugs

Bicyclic Oxazole

Pyridine Derivatives

Notch Sparing

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10000499 - Methyl diazepane orexin receptor antagonists (2018-06-19),

2. 9994570 - Bridged diazepane orexin receptor antagonists (2018-06-12),

3. 9987255 - 5,5-bicyclic oxazole orexin receptor antagonists (2018-06-05),

4. 9732077 - Diazepane orexin receptor antagonists (2017-08-15),

5. 9663513 - Pyrimidine PDE10 inhibitors (2017-05-30),

6. 9428492 - Secondary alcohol substituted triazoles as PDE10 inhibitors (2016-08-30),

7. 9365562 - 1,3 substituted azetidine PDE10 inhibitors (2016-06-14),

8. 9359348 - Cyclopropyl imidazopyridine PDE10 inhibitors (2016-06-07),

9. 9353104 - Substituted pyridizinone derivatives as PDE10 inhibitors (2016-05-31),

10. 9284302 - Cyclobutyl benzimidazoles as PDE 10 inhibitors (2016-03-15),

11. 9273033 - Substituted pyridone derivatives as PDE10 inhibitors (2016-03-01),

12. 9200001 - Triazolyl PDE10 inhibitors (2015-12-01),

13. 8871796 - Diaryl ether derivatives as notch sparing gamma secretase inhibitors (2014-10-28),

14. 8637513 - Heterocycle phenyl amide T-type calcium channel antagonists (2014-01-28),

15. 8592457 - Isonicotinamide orexin receptor antagonists (2013-11-26),

Title: The Innovative Mind of Thomas S Reger

Introduction: Thomas S Reger, a talented inventor hailing from Lansdale, PA, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Thomas S Reger's latest patents include a cutting-edge software application for enhancing cybersecurity measures in financial institutions and a revolutionary medical device designed to improve patient outcomes in critical care settings.

Career Highlights: With over two decades of experience in the tech industry, Thomas S Reger has a proven track record of developing innovative solutions to complex problems. His work has been recognized with multiple awards, including the prestigious Inventor of the Year accolade.

Collaborations: Throughout his career, Thomas S Reger has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Thomas S Reger's passion for innovation and his dedication to pushing the boundaries of technology make him a true pioneer in the field of inventing. His work continues to inspire the next generation of inventors to think creatively and strive for excellence in their pursuits.

Profile summary based on public USPTO records.